Orion Portfolio Solutions’s Vaxcyte PCVX Stock Holding History

Orion Portfolio Solutions’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$487K	Buy	+12,905	New	+$1.03M	﹤0.01%	1436
2024 Q4	–	Sell	-2,590	Closed	-$296K	–	1887
2024 Q3	$296K	Sell	2,590 -1,991	-43%	-$179K	﹤0.01%	1526
2024 Q2	$346K	Sell	4,581 -267	-6%	-$18.2K	﹤0.01%	1412
2024 Q1	$331K	Sell	4,848 -2,457	-34%	-$170K	﹤0.01%	1420
2023 Q4	$443K	Buy	7,305 +1,050	+17%	+$54.5K	0.01%	1261
2023 Q3	$319K	Buy	+6,255	New	+$309K	﹤0.01%	1351

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Orion Portfolio Solutions's PCVX Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Vaxcyte (PCVX) in Q1 2025: 12,905 shares worth $487K. The stake represents ﹤0.01% of the portfolio and ranks #1436 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in PCVX as recently as Q3 2024.

Orion Portfolio Solutions first reported a position in PCVX in Q3 2023 and has held it in 6 quarters since. 315 funds tracked by Wall St. Rank hold PCVX as of Q1 2025.

Orion Portfolio Solutions held 12,905 shares of Vaxcyte worth $487K as of Q1 2025.
Vaxcyte was a new Orion Portfolio Solutions position in Q1 2025.
Vaxcyte made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1436 holding.
Orion Portfolio Solutions first reported a position in Vaxcyte in Q3 2023 and has held it in 6 quarters since.
315 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.